Brief: Knight Therapeutics Reports Q1 Results

Knight Therapeutics

14/05/2021 13:03

May 14 (Reuters) - Knight Therapeutics Inc  GUD.TO :
    * QTRLY REVENUES WERE C$46.1 MILLION ($38.03 MILLION),
INCREASE OF
1% OVER PRIOR YEAR
    * QTRLY DILUTED EARNINGS PER SHARE C$0.03
    * Q1 EARNINGS PER SHARE VIEW C$-0.02, REVENUE VIEW C$48.7
MILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5tpZ8T 
Further company coverage:  GUD.TO 

($1 = 1.2122 Canadian dollars)

 ((Reuters.Briefs@thomsonreuters.com;))